000			01517cam a2200289 4500
005			20150716091049.0
008			021119s xx 000 0 eng
022			_a1522-3248;
050		0	_aAC1.S5
082	0		_a050
100	1		_aBogdanich, Walt.
245	1	0	_aWhen a Buyer for Hospitals Has a Stake in Drugs It Buys. / _cWalt Bogdanich and others.
260			_bNew York Times, _c2002.
440		0	_aSIRS Enduring Issues 2003. _nArticle 4. _pHuman Relations, _x1522-3248;
500			_aArticles Contained in SIRS Enduring Issues 2003.
500			_aOriginally Published: When a Buyer for Hospitals Has a Stake in Drugs It Buys, March 26, 2002; pp. A1+.
520			_a"Hospital buying groups are middlemen, negotiating contracts with suppliers of products and services. But unlike most other purchasing agents, these groups are not financed by the hospitals that buy products, but by the companies that sell them, raising questions about whose interests the buying groups serve." (NEW YORK TIMES) This article examines how a hospital buying group's financial interest in the drug company it buys from has raised ethical concerns.
599			_aRecords created from non-MARC resource.
650		0	_aConflict of interests.
650		0	_aHospital purchasing.
650		0	_aHospitals.
650		0	_aMedical ethics.
650		0	_aPharmaceutical ethics.
650		0	_aPharmaceutical industry.
710	2		_aSIRS Publishing, Inc. _tSIRS Enduring Issues 2003. _pHuman Relations., _x1522-3248.
942			_c UKN
999			_c34458 _d34458